Zoryve Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Zoryve
O
- obeticholic acid
- Ocaliva (obeticholic acid)
- Ocella (drospirenone / ethinyl estradiol)
- Ogestrel 0.5 / 50 (ethinyl estradiol / norgestrel)
- ombitasvir / paritaprevir / ritonavir
- Omeclamox-Pak (amoxicillin / clarithromycin / omeprazole)
- Onmel (itraconazole)
- Onsura (ethinyl estradiol / norelgestromin)
- Orkambi (ivacaftor / lumacaftor)
- Orladeyo (berotralstat)
- Orsythia (ethinyl estradiol / levonorgestrel)
- Ortho Cyclen (ethinyl estradiol / norgestimate)
- Ortho Evra (ethinyl estradiol / norelgestromin)
- Ortho Tri-Cyclen (ethinyl estradiol / norgestimate)
- Ortho Tri-Cyclen Lo (ethinyl estradiol / norgestimate)
- Ortho-Cept (desogestrel / ethinyl estradiol)
- Ortho-Novum 1 / 35 (ethinyl estradiol / norethindrone)
- Ortho-Novum 10 / 11 (ethinyl estradiol / norethindrone)
- Ortho-Novum 7 / 7 / 7 (ethinyl estradiol / norethindrone)
- Oshih (ethinyl estradiol / norethindrone)
- osilodrostat
- Ovcon 35 (ethinyl estradiol / norethindrone)
- Ovcon 35 Fe (ethinyl estradiol / norethindrone)
- Ovcon 50 (ethinyl estradiol / norethindrone)
- Ovral (ethinyl estradiol / norgestrel)
- Ovral-21 (ethinyl estradiol / norgestrel)
- Ovral-28 (ethinyl estradiol / norgestrel)
- Oxbryta (voxelotor)
- Oxsoralen-Ultra (methoxsalen)
More about Zoryve (roflumilast topical)
- Zoryve consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (32)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.